| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Oracle Health customers can easily sign up today to participate and capture data from across the healthcare ecosystem to create...
Investor Michael Burry pushed back against critics who challenged his take on chip depreciation at hyperscalers like Meta Platf...
Investors anticipate Nvidia's earnings report, betting on a potential year-end tech rally amid demand for AI chips and part...
Baird analyst Rob Oliver maintains Oracle (NYSE:ORCL) with a Outperform and lowers the price target from $365 to $315.